Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon Scoops Up $20M in VC Cash for Product Development

NEW YORK, June 2 (GenomeWeb News) - Exiqon's has emerged from a third round of financing with $20 million in funding, the Danish company reported today.

The company plans to use the cash to support product development, sales and marketing, and loan repayment, according to a statement.

Exiqon is launching "a number" of miRURY microRNA analysis products "as well as other products," the company said. The firm recently signed a distribution agreement with Roche Diagnostics for its ProbeLibrary real-time PCR kits, Exiqon added.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.